biotactical
Oegstgeest
About biotactical
Biotactical develops next-generation Rapid Microbial Methods for pharmaceutical manufacturing. The company focuses on reducing the microbial detection time from 14-21 days to 48-72 hours, enhancing quality control and assurance processes. Biotactical's solutions are designed for pharmaceutical manufacturers and Contract Development and Manufacturing Organizations (CDMOs), aiming to improve pandemic preparedness and antimicrobial resistance diagnostics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: biotactical.nl
Industries & Categories
Biotechnology, Medical, Test and Measurement
Social Profiles
Canonical: https://fsome.com/organization/biotactical-2416272 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.